Advancing market-access marketing through experiential strategy, effective value demonstration, and market-access-focused resource development.

Joined April 2016
ow.ly/VARF50HrXVj The Home Health Value-Based Purchasing Model has done much to improve the state of care in the home; but there is still more to do.
When it comes to creating #pharma campaigns with impact, our Pam Caputo is the leader you want by your side. She chats with @OutcomesRocket about #bigdata, #behaviorchange and how to leverage both to create a campaign that delivers results: outcomesrocket.health/precis…
5
5
PRECISIONvalue retweeted
Interesting #biosims article from @Precisionforval "In the EU...adoption rates have been highest where there is a cohesive, integrated approach in which all parties (i.e., physicians, payers, pharmacists, policy makers) cooperate to realize cost savings." bit.ly/2Y1pQpz
1
1
This one is close to my heart...my mom had lung CA. New therapies extended her life...for the birth of her 1st grandchild…my sister's HS graduation…and my doctoral graduation. Thanks @IVI_health @LUNGevity for incorporating the #patient voice into #value models #innovation
We’re looking forward to comments on our open-source value platform model to assess value in non-small cell lung cancer therapies. Transparency & collaboration are why we release all model materials and invite input. Value models improve with input!! bit.ly/2WvIMNw
7
2
14
PRECISIONvalue retweeted
.@Precisionforval's @Danrenick1: "The most rewarding aspect of an integrated approach is seeing the increased likelihood that appropriate #patients receive the medical innovations that truly improve and extend their lives." #hcmktg #pharma #healthcare bit.ly/2AQEgAs
1
1
Jeremy Schafer SVP @Precisionforval explains how #pharma may have to put prices in their drug commercials and what that means for drug companies and consumers. @clintrials365 knect365.com/clinical-trials…
3
3
What does your schedule look like for #ISPOREU? You don't want to miss these sessions with our experts! You can also connect with them at booth 311!
2
2
Data size does matter. Read how small data is the next-generation data management system for biopharma. ow.ly/vOa530mtDkc
2
1
Replying to @PRECISIONvalue
@Precisionforval's Dan Renick loves these #healthcare executive #interview question. Read it @MHExecutive buff.ly/2DoMlzl
1
2
"The PIE guidance allows manufacturers to engage payers about information, including the clinical trial results, patient utilization projections, and pricing information" - Jeremy Schafer, @Precisionforval spr.ly/6011Dtczh
1
2
Replying to @PRECISIONvalue
@Precisionforval's Joseph Honcz, RPh, MBA, vice president of Payer Access Solutions, talks to @MHExecutive about how a new #drugpricing act could affect #drug prices buff.ly/2B3uU6q
1
2
PRECISIONvalue retweeted
Jeremy Schafer of @Precisionforval hypothesizes when it comes to gene therapies, the U.S. healthcare system is not built for rewarding one-time products with long-term benefits. “I think we saw the first inklings of this when Sovaldi came up for hep C.” MedAdNews.com
1
2
PRECISIONvalue retweeted
“Gene therapies have been talked about for many years, and they are becoming a commercial reality, but I think there’s still work to be done to making these new treatments effective,” @Precisionforval’s Alex Grosvenor said in MedAdNews.com’s Payer Access special feature
1
3
3 Steps To Capitalize On Real-World Data Under 21st Century Cures By Dominic Galante, M.D., @Precisionforval okt.to/Fu4qaE
1
2
Approval secured, next test for Otsuka/Proteus digital drug is improving adherence: mmm-online.com/technology/fi… @Precisionforval
Good timeline @Precisionforval #NicolaAllen #ISPORGlasgow
3
2
Join Precision Oncology's guided discussions at #ASCO17 Where: Precision Oncology, booth #2124 June-04 @3:15 pm
Join Precision Oncology's guided discussions at #ASCO17 Where: Precision Oncology, booth #2124 June-03 @3:15 pm
Precision Oncology: Strategically Located To Accelerate Oncology Drug Development. Visit us at #ASCO17 (Booth 2124)
Precision Oncology is leading the paradigm shift in oncology drug development. Visit us at #ASCO17 (Booth 2124) to learn how!
3
2